Darrell R. Brown - 01 Mar 2023 Form 4 Insider Report for ECOLAB INC. (ECL)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Mar 2023, 17:00:38 UTC
Prior SEC filing
24 Feb 2023
Next SEC filing
08 Dec 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ David F. Duvick, as Attorney-in-Fact for Darrell R. Brown

Key filing fact

Darrell R. Brown filed Form 4 for ECOLAB INC. (ECL) on 03 Mar 2023.

Key facts

  • This page summarizes Darrell R. Brown's Form 4 filing for ECOLAB INC. (ECL).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Mar 2023, 17:00.

Change

  • Previous filing in this sequence was filed on 24 Feb 2023.
  • Current net transaction value: -$147,188.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ECL transaction

Common Stock

Tax liability

Transaction value
$147,188
Shares
-926
Change %
-3.9%
Price
$158.95
Shares after
23,084
Date
01 Mar 2023
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects the reporting person's payment of minimum statutory tax obligations by withholding shares of Ecolab Common Stock incident to the settlement of vested performance-based restricted stock units in accordance with Rule 16b-3.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .